These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26186456)

  • 1. Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal.
    Guillermet E; Dicko HM; Mai le TP; N'Diaye M; Hane F; Ba SO; Gomis K; Tho NT; Lien NT; Than PD; Dinh TV; Jaillard P; Gessner BD; Colombini A
    PLoS One; 2015; 10(7):e0132292. PubMed ID: 26186456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
    Sutanto A; Suarnawa IM; Nelson CM; Stewart T; Soewarso TI
    Bull World Health Organ; 1999; 77(2):119-26. PubMed ID: 10083709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
    Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru.
    Nogier C; Hanlon P; Wiedenmayer K; Maire N
    Drugs Real World Outcomes; 2015 Mar; 2(1):43-52. PubMed ID: 27747612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia.
    Kanagat N; Krudwig K; Wilkins KA; Kaweme S; Phiri G; Mwansa FD; Mvundura M; Robertson J; Kristensen D; Gueye A; Dao SD; Thai PQ; Nguyen HT; Tran TC
    Glob Health Sci Pract; 2020 Dec; 8(4):680-688. PubMed ID: 33361235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case study of an influenza vaccination program for health care workers in Vietnam.
    Ha NT; Nguyen TTM; Nguyen TX; Tran PD; Nguyen HM; Ha VT; Lafond KE; Seward JF; McFarland JW; Chu SY
    BMC Health Serv Res; 2020 Aug; 20(1):785. PubMed ID: 32831071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
    Drain PK; Nelson CM; Lloyd JS
    Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study.
    Seaman CP; Morgan C; Howell J; Xiao Y; Spearman CW; Sonderup M; Lesi O; Andersson MI; Hellard ME; Scott N
    Lancet Glob Health; 2020 Jul; 8(7):e931-e941. PubMed ID: 32562649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.
    Sedita J; Perrella S; Morio M; Berbari M; Hsu JS; Saxon E; Jarrahian C; Rein-Weston A; Zehrung D
    Vaccine; 2018 Mar; 36(12):1700-1709. PubMed ID: 29449099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reuse prevention syringes for reconstitution of lyophilized vaccines: Operational study and UNICEF plans for expanding introduction.
    Fleming JA; Hoekstra EJ; Moniaga V; Widjaya A; Soepardi J; Supartha N; Salovaara A; Khamassi S; Nelson C
    Int J Occup Environ Health; 2009; 15(1):9-13. PubMed ID: 19267121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of complete immunization among senegalese children aged 12-23 months: evidence from the demographic and health survey.
    Mbengue MAS; Sarr M; Faye A; Badiane O; Camara FBN; Mboup S; Dieye TN
    BMC Public Health; 2017 Jul; 17(1):630. PubMed ID: 28683781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countries.
    Guillermet E; Alfa DA; Phuong Mai LT; Subedi M; Demolis R; Giersing B; Jaillard P
    Vaccine; 2019 Jul; 37(32):4435-4443. PubMed ID: 30890383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan: protocol for a randomized controlled trial.
    Siddiqi DA; Munir M; Shah MT; Khan AJ; Chandir S
    BMC Public Health; 2019 Oct; 19(1):1421. PubMed ID: 31666039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach.
    Mbengue MAS; Mboup A; Ly ID; Faye A; Camara FBN; Thiam M; Ndiaye BP; Dieye TN; Mboup S
    Pan Afr Med J; 2017; 27(Suppl 3):8. PubMed ID: 29296143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle].
    Schlumberger M; Châtelet IP; Lafarge H; Genêt A; Gaye AB; Monnereau A; Sanou C; Diawara L; Gueye Y; Lang J
    Sante; 1999; 9(5):319-26. PubMed ID: 10657777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
    Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
    Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
    Mvundura M; Frivold C; Janik Osborne A; Soni P; Robertson J; Kumar S; Anena J; Gueye A; Menozzi-Arnaud M; Giersing B; Kahn AL; Scarna T; Kristensen D
    Vaccine; 2021 Dec; 39(49):7195-7207. PubMed ID: 34412922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis.
    Dutta T; Agley J; Meyerson BE; Barnes PA; Sherwood-Laughlin C; Nicholson-Crotty J
    PLoS One; 2021; 16(6):e0253318. PubMed ID: 34170920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.